Unknown

Dataset Information

0

Nanoparticle enrichment mass-spectrometry proteomics identifies protein-altering variants for precise pQTL mapping.


ABSTRACT: Proteogenomics studies generate hypotheses on protein function and provide genetic evidence for drug target prioritization. Most previous work has been conducted using affinity-based proteomics approaches. These technologies face challenges, such as uncertainty regarding target identity, non-specific binding, and handling of variants that affect epitope affinity binding. Mass spectrometry-based proteomics can overcome some of these challenges. Here we report a pQTL study using the Proteograph™ Product Suite workflow (Seer, Inc.) where we quantify over 18,000 unique peptides from nearly 3000 proteins in more than 320 blood samples from a multi-ethnic cohort in a bottom-up, peptide-centric, mass spectrometry-based proteomics approach. We identify 184 protein-altering variants in 137 genes that are significantly associated with their corresponding variant peptides, confirming target specificity of co-associated affinity binders, identifying putatively causal cis-encoded proteins and providing experimental evidence for their presence in blood, including proteins that may be inaccessible to affinity-based proteomics.

SUBMITTER: Suhre K 

PROVIDER: S-EPMC10837160 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nanoparticle enrichment mass-spectrometry proteomics identifies protein-altering variants for precise pQTL mapping.

Suhre Karsten K   Venkataraman Guhan Ram GR   Guturu Harendra H   Halama Anna A   Stephan Nisha N   Thareja Gaurav G   Sarwath Hina H   Motamedchaboki Khatereh K   Donovan Margaret K R MKR   Siddiqui Asim A   Batzoglou Serafim S   Schmidt Frank F  

Nature communications 20240202 1


Proteogenomics studies generate hypotheses on protein function and provide genetic evidence for drug target prioritization. Most previous work has been conducted using affinity-based proteomics approaches. These technologies face challenges, such as uncertainty regarding target identity, non-specific binding, and handling of variants that affect epitope affinity binding. Mass spectrometry-based proteomics can overcome some of these challenges. Here we report a pQTL study using the Proteograph™ P  ...[more]

Similar Datasets

2023-12-19 | PXD042852 | Pride
2024-10-31 | MSV000096270 | MassIVE
| EGAC00001002236 | EGA
| S-EPMC6203843 | biostudies-literature
| S-EPMC11526168 | biostudies-literature
| S-EPMC11418007 | biostudies-literature
| S-EPMC4047475 | biostudies-literature
| S-EPMC7968110 | biostudies-literature
| S-EPMC4838941 | biostudies-other
| S-EPMC10473190 | biostudies-literature